{"id":"https://openalex.org/W2007997520","doi":"https://doi.org/10.1007/s00280-003-0642-8","title":"Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer","display_name":"Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer","publication_year":2003,"publication_date":"2003-09-01","ids":{"openalex":"https://openalex.org/W2007997520","doi":"https://doi.org/10.1007/s00280-003-0642-8","mag":"2007997520","pmid":"https://pubmed.ncbi.nlm.nih.gov/12783206"},"language":"en","primary_location":{"id":"doi:10.1007/s00280-003-0642-8","doi":"https://doi.org/10.1007/s00280-003-0642-8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-003-0642-8","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.25405/ncl.34651224","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042403751","display_name":"Bruno G. Reigner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Bruno Reigner","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland. bruno.reigner@roche.com","F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland. bruno.reigner@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010011336","display_name":"Toru Watanabe","orcid":"https://orcid.org/0000-0002-3333-5443","observed_orcids":["https://orcid.org/0000-0002-3333-5443"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toru Watanabe","raw_affiliation_strings":["National Cancer Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Hospital, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5097696211","display_name":"Johannes Sch\ufffdller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111069","display_name":"Krankenanstalt Rudolfstiftung der Stadt Wien","ror":"https://ror.org/019myg640","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210111069","https://openalex.org/I4210117134"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Johannes Sch\ufffdller","raw_affiliation_strings":["Hospital Rudolfstiftung, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Rudolfstiftung, Vienna, Austria","institution_ids":["https://openalex.org/I4210111069"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108654411","display_name":"Helen H. Lucraft","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen Lucraft","raw_affiliation_strings":["Newcastle General Hospital, Newcastle upon Tyne, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Newcastle General Hospital, Newcastle upon Tyne, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103187201","display_name":"Yasutsuna Sasaki","orcid":"https://orcid.org/0000-0002-6712-7116","observed_orcids":["https://orcid.org/0000-0002-6712-7116"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasutsuna Sasaki","raw_affiliation_strings":["National Cancer Center East Hospital, Kashiwa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Center East Hospital, Kashiwa, Japan","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083898918","display_name":"John A. Bridgewater","orcid":"https://orcid.org/0000-0001-9186-1604","observed_orcids":["https://orcid.org/0000-0001-9186-1604"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Bridgewater","raw_affiliation_strings":["University College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034349158","display_name":"Toshiaki Saeki","orcid":"https://orcid.org/0000-0002-8893-9519","observed_orcids":["https://orcid.org/0000-0002-8893-9519"]},"institutions":[{"id":"https://openalex.org/I4210141613","display_name":"Shikoku Cancer Center","ror":"https://ror.org/03yk8xt33","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137409","https://openalex.org/I4210141613"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiaki Saeki","raw_affiliation_strings":["National Shikoku Cancer Center, Matsuyama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Shikoku Cancer Center, Matsuyama, Japan","institution_ids":["https://openalex.org/I4210141613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103583452","display_name":"James J McAleer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802808109","display_name":"Belfast City Hospital","ror":"https://ror.org/02405mj67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1289110261","https://openalex.org/I2802808109"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James McAleer","raw_affiliation_strings":["Belfast City Hospital, Belfast, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belfast City Hospital, Belfast, UK","institution_ids":["https://openalex.org/I2802808109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002049972","display_name":"Masaru Kuranami","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masaru Kuranami","raw_affiliation_strings":["Kitasako University School of Medicine, Sagamihara, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kitasako University School of Medicine, Sagamihara, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109567331","display_name":"Christopher John Poole","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Christopher Poole","raw_affiliation_strings":["Cancer Research UK, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK, Birmingham, UK","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091398968","display_name":"Mitsunori Kimura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112136","display_name":"Roche (Japan)","ror":"https://ror.org/01vepzj85","country_code":"JP","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210112136"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsunori Kimura","raw_affiliation_strings":["Nippon Roche, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nippon Roche, Tokyo, Japan","institution_ids":["https://openalex.org/I4210112136"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021819920","display_name":"Jayne Monkhouse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113058","display_name":"Roche (United Kingdom)","ror":"https://ror.org/024tgbv41","country_code":"GB","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210113058"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jayne Monkhouse","raw_affiliation_strings":["Roche Products, Welwyn, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Products, Welwyn, UK","institution_ids":["https://openalex.org/I4210113058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029711459","display_name":"Cahit Yorulmaz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Cahit Yorulmaz","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025796935","display_name":"Erhard Weidekamm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Erhard Weidekamm","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073170258","display_name":"Susan Grange","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Susan Grange","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5042403751"],"corresponding_institution_ids":["https://openalex.org/I118019719"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":2.0526,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.85392835,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"52","issue":"3","first_page":"193","last_page":"201"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8065999746322632,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8065999746322632,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.060499999672174454,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.03519999980926514,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9409999847412109},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8849999904632568},{"id":"https://openalex.org/keywords/5-deoxy-5-fluorouridine","display_name":"5'-deoxy-5-fluorouridine","score":0.8870000243186951},{"id":"https://openalex.org/keywords/5-deoxy-5-fluorocytidine","display_name":"5'-deoxy-5-fluorocytidine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9959999918937683},{"id":"https://openalex.org/keywords/alpha-fluoro-beta-alanine","display_name":"alpha-fluoro-beta-alanine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/racial-differences","display_name":"racial differences","score":0.7289999723434448},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.8849999904632568},{"id":"https://openalex.org/keywords/white-patients","display_name":"Caucasian patients","score":0.9980000257492065},{"id":"https://openalex.org/keywords/fluoropyrimidine","display_name":"fluoropyrimidine","score":0.5989999771118164},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.6169999837875366},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.9550034999847412},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8959916234016418},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7673280239105225},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.5908167958259583},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5385037660598755},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.529857337474823},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4799799621105194},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44656825065612793},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42202818393707275},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.42031610012054443},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.4130176901817322},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36689692735671997},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36104416847229004},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.09635606408119202}],"mesh":[{"descriptor_ui":"D000069287","descriptor_name":"Capecitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001711","descriptor_name":"Biotransformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015091","descriptor_name":"beta-Alanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015091","descriptor_name":"beta-Alanine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044465","descriptor_name":"White People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1007/s00280-003-0642-8","doi":"https://doi.org/10.1007/s00280-003-0642-8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-003-0642-8","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:12783206","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12783206","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Clinical Trial"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:31059","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/31059/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"CANCER CHEMOTHERAPY AND PHARMACOLOGY , 52 (3) pp. 193-201. (2003)","raw_type":"Article"},{"id":"doi:10.25405/ncl.34651224","doi":"https://doi.org/10.25405/ncl.34651224","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34651224","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.25405/ncl.34651224.v1","doi":"https://doi.org/10.25405/ncl.34651224.v1","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34651224.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.25405/ncl.34651224","doi":"https://doi.org/10.25405/ncl.34651224","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34651224","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1773171357","https://openalex.org/W1910716144","https://openalex.org/W1939003096","https://openalex.org/W1967326783","https://openalex.org/W1972953023","https://openalex.org/W1976866846","https://openalex.org/W1979937973","https://openalex.org/W1980762644","https://openalex.org/W1982182115","https://openalex.org/W1986952772","https://openalex.org/W2006271273","https://openalex.org/W2029443629","https://openalex.org/W2035384960","https://openalex.org/W2044970916","https://openalex.org/W2046311020","https://openalex.org/W2059456816","https://openalex.org/W2068781026","https://openalex.org/W2078221442","https://openalex.org/W2086488031","https://openalex.org/W2090941375","https://openalex.org/W2103221219","https://openalex.org/W2123732467","https://openalex.org/W2131770017","https://openalex.org/W2137194656","https://openalex.org/W2138577761","https://openalex.org/W2138926750","https://openalex.org/W2140626944","https://openalex.org/W2146295084","https://openalex.org/W2165757143","https://openalex.org/W2184311280","https://openalex.org/W2599409825","https://openalex.org/W2889254222"],"related_works":["https://openalex.org/W1950204311","https://openalex.org/W111536681","https://openalex.org/W2770258158","https://openalex.org/W2080863341","https://openalex.org/W2381807597","https://openalex.org/W1853577420","https://openalex.org/W2590355695","https://openalex.org/W2405514669","https://openalex.org/W1994378934","https://openalex.org/W2365789257"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}